Article

Redesigning and Revaluing HSA Plans

Amid two seemingly unrelated trends, the rise of high-deductible health plans and the growing prevalence and burden of chronic diseases, it may time to rethink the concept and regulation of preventive services, argue advocates of value-based insurance.

Amid two seemingly unrelated trends, the rise of high-deductible health plans and the growing prevalence and burden of chronic diseases, it may time to rethink the concept and regulation of preventive services, argue advocates of value-based insurance.

Any of the 18 million Americans diagnosed with diabetes and enrolled in a high-deductible health plan with a health savings account has to pay for glucose, blood pressure, cholesterol and eye tests, among other necessities, out-of-pocket before hitting their deductible, as dictated by Internal Revenue Service regulations for HSA-eligible plans.

Depending on a person’s income, that can be a disincentive to get a test or take a medication in the short-run, but in the long-run potentially lead to avoidable complications and unnecessary spending.

Read the full story here: http://bit.ly/1guYmN1

Source: Healthcare Payer News

Related Videos
Alexander Mathioudakis, MD, PhD, clinical lecturer in respiratory medicine at The University of Manchester
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
Klaus Rabe, MD, PhD, chest physician and professor of medicine, University of Kiel
dr jennifer green
dr jennifer green
dr ken cohen
dr ian neeland
dr surya bhatt
dr surya bhatt
Yael Mauer, MD, MPH
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo